期刊文献+

CoaguChek XS血凝仪检测国际标准化比值和凝血酶原时间的准确性和可靠性 被引量:5

Accuracy and reliability of CoaguChek XS coagulometer for measuring international normalized ratio and prothrombin time
下载PDF
导出
摘要 目的比较罗氏CoaguChek XS快速凝血分析仪与标准实验室静脉血测定的国际标准化比值(INR)和凝血酶原时间之间的差异,判断CoaguChek XS测量INR的准确性。方法 80例患者同时抽取静脉血及指端毛细血管血,分别行标准实验室INR测定及罗氏CoaguChek XS快速凝血分析仪INR测定。结果 2种测量方法差异无统计学意义(P>0.05)。CoaguChek XS INR与标准实验室测定的INR呈正相关(r=0.987,P>0.05)。92.5%的患者更愿意接受CoaguChek XS测定INR。结论罗氏CoaguChek XS快速凝血分析仪测定INR结果可靠,具有快速、简便、准确、疼痛小、依从性好等特点,能很快提供可靠数据,便于临床医师及时调整抗凝药物剂量。 Objective To compare the differences of internalional normalized ratio(INR) and prothrombin time measured by CoaguChek XS coagulometer and standard laboratory venous blood measurement in order to judge accuracy of measuring INR by CoaguChek XS. Methods Venous blood and finger capillary blood were taken simullaneously from 80 patients for measurement of INR by standard laboratory assay and CoaguChek XS coagulometer respectively. Results The 2 measuring methods had no statistically significant difference. The INR measured by CoaguChek (R) XS system had positive correlation with that measured by standard assays. Of 80 respondents surveyed,92.5% preferred CoaguChek XS measurement of INR. Conclusion CoaguChek XS coagulometer can accurately and precisely measure INR in the elderly and is compared to standard laboratory INR test. It can be used in busy anticoagulation department of hospital.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2010年第6期521-522,共2页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 国际标准化比 凝血酶原时间 华法林 可重复性 结果 international normalized ratio prothrombin time warfarin reproducibility of results
  • 相关文献

参考文献4

二级参考文献30

  • 1韩雅玲,王祖禄.心房颤动患者血栓栓塞并发症的防治[J].中国实用内科杂志,2006,26(2):177-179. 被引量:34
  • 2孙艺红.华法林的临床应用与监测[J].中国实用内科杂志,2007,27(9):657-660. 被引量:26
  • 3[9]Poli D,Antonucei E,Cecchi E,et al.Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation:the role of homocysteine[J].Stroke,2005,36(10):2159-2163. 被引量:1
  • 4[10]Fang MC,Singer DE,Chang Y,et al.Gender differences in the risk of ischemie stroke and peripheral embolism inatrial fibrillation:the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study[J].Circulation,2005,112(12):1687-1691. 被引量:1
  • 5[11]Lip GY,Hart RG,Conway DS.Antithrombotic therapy for atrial fibrillation[J].BMJ,2002,325 (7371):1022-1025. 被引量:1
  • 6[12]Fuster V,Ryden LE,Cannom DS,et al.ACC/AHA/ESC2006 guidelines for the management of patients with atrial fibrillation-executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation)[J].J Am Coil Cardiol,2006,48(4):854906. 被引量:1
  • 7[13]Go AS,Fang MC,Singer DE.Antithrombotic therapy for stroke prevention in atrial fibrillation[J].Prog Cardiovasc Dis,2005,48(2):108-124. 被引量:1
  • 8[14]Economides Munoz C,Singh BN.Antithrombotic therapies for stroke prevention in atrial fibrillation[J].Minerva Cardioangiol,2004,52 (2):125-139. 被引量:1
  • 9[15]O'Donnell M,Weitz JI.Emerging therapies for stroke prevention in atrial fibrillation[J].Eur Heart J,2005,7(Suppl C):C19-C27. 被引量:1
  • 10[16]Ostermayer SH,Reisman M,Kramer PH,et al.Percutaneous left atrial appendage transcatheter occlusion(PLAATO system)to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation:results from the international multi-center feasibility trials[J].J Am CoilCardiol,2005,46(1):9-14. 被引量:1

共引文献48

同被引文献71

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部